Literature DB >> 10975995

Disulfiram inhibits TNF-alpha-induced cell death.

A Zhao1, Z Q Wu, M Pollack, F M Rollwagen, P Hirszel, X Zhou.   

Abstract

Disulfiram, a clinically employed alcohol deterrent, was recently discovered to inhibit caspase-3 and DNA fragmentation. Using LLC-PK1 cells and murine liver as models, we examined if the drug inhibited TNF-alpha-induced cell death. Disulfiram produced dose-dependent inhibition of TNF-alpha-induced cell death as well as caspase-3-like activity. Disulfiram retained 80% of its effect when added 4 h after TNF-alpha. Disulfiram protected the cells from cytokine-induced death for at least 6 days. The cells rescued by the drug preserved the ability to proliferate. The cells died spontaneously after exposure to TNF-alpha for just 70 min. Co-administration of 15 microM disulfiram and TNF-alpha for 70 min prior to their removal abolished TNF-alpha-induced killing, and this was associated with restoration of mitochondrial membrane potential and suppression of reactive oxygen species. Treatment of mice with TNF-alpha and D-galactosamine for 5 h markedly increased hepatic DNA fragmentation and caspase-3-like activity. Disulfiram at 0.6 mmol/kg abolished these effects. We conclude that disulfiram is a potent inhibitor of TNF-alpha-induced cell death in vitro. The underlying mechanisms include stabilization of mitochondrial membrane potential, suppression of reactive oxygen species, and inhibition of caspase-3-like activity. We further conclude that disulfiram inhibits DNA fragmentation in vivo in association with the blockade of caspase-3-like activity. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10975995     DOI: 10.1006/cyto.2000.0725

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  2 in total

1.  Honokiol is a potent scavenger of superoxide and peroxyl radicals.

Authors:  Sergey Dikalov; Tanya Losik; Jack L Arbiser
Journal:  Biochem Pharmacol       Date:  2008-07-02       Impact factor: 5.858

2.  The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance.

Authors:  Juliana Almeida-Silva; Diego Silva Menezes; Juan Mateus Pereira Fernandes; Márcio Cerqueira Almeida; Deyvison Rhuan Vasco-Dos-Santos; Roberto Magalhães Saraiva; Alessandra Lifsitch Viçosa; Sandra Aurora Chavez Perez; Sônia Gumes Andrade; Ana Márcia Suarez-Fontes; Marcos André Vannier-Santos
Journal:  Front Cell Infect Microbiol       Date:  2022-07-29       Impact factor: 6.073

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.